资讯
10 小时
News-Medical.Net on MSNGLP-1 weight-loss drugs are reshaping modern dating and intimacyGLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.
GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.
People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new ...
20 小时on MSN
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
After the American Academy of Pediatrics recommended the use of certain GLP-1 weight loss drugs in January of 2023, the use ...
Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...
New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
5 天
MedPage Today on MSNGLP-1 Therapy Helps Amplify Bariatric Surgery Weight Loss, But Timing MattersIn 568 patients who underwent bariatric surgery, those who also used a GLP-1 receptor agonist during the preoperative and ...
2 天
India Today on MSNA complete guide to weight loss using anti-obesity GLP-1 medicationsThe launch of GLP-1 weight-loss drugs in India is gaining popularity. Harvard researchers share a comprehensive guidance for sustainable weight loss.
1 小时
HealthDay on MSNGLP-1 Medications May Increase the Risk of Severe Acid RefluxPeople using GLP-1 medications are more likely to suffer severe acid reflux, a new study suggests.Researchers found patients with type 2 diabetes taking GLP-1s ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果